These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 35613880)

  • 1. Cerebral Edema Due to Chemotherapeutic Wafer Implantation for Malignant Glioma: Registry Study of Correlation with Perioperative Epileptic Seizures.
    Fujii Y; Ogiwara T; Kato H; Hanaoka Y; Hardian RF; Goto T; Hongo K; Horiuchi T
    Neurol Med Chir (Tokyo); 2022 Jul; 62(7):328-335. PubMed ID: 35613880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative analysis of brain edema in patients with malignant glioma treated with BCNU wafers.
    Murai S; Ichikawa T; Kurozumi K; Shimazu Y; Oka T; Otani Y; Shimizu T; Date I
    J Clin Neurosci; 2016 Nov; 33():148-153. PubMed ID: 27452129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First-line treatment of malignant glioma with carmustine implants followed by concomitant radiochemotherapy: a multicenter experience.
    Bock HC; Puchner MJ; Lohmann F; Schütze M; Koll S; Ketter R; Buchalla R; Rainov N; Kantelhardt SR; Rohde V; Giese A
    Neurosurg Rev; 2010 Oct; 33(4):441-9. PubMed ID: 20706757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety profile of carmustine wafers in malignant glioma: a review of controlled trials and a decade of clinical experience.
    Sabel M; Giese A
    Curr Med Res Opin; 2008 Nov; 24(11):3239-57. PubMed ID: 18940042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postoperative seizure in high grade glioma patients treated with BCNU wafers. A mono-institutional experience.
    Della Puppa A; Denaro L; Rossetto M; Ciccarino P; Manara R; Lombardi G; Del Moro G; Rotilio A; d'Avella D; Scienza R
    J Neurooncol; 2011 Nov; 105(2):275-80. PubMed ID: 21505945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multicenter phase I/II study of the BCNU implant (Gliadel(®) Wafer) for Japanese patients with malignant gliomas.
    Aoki T; Nishikawa R; Sugiyama K; Nonoguchi N; Kawabata N; Mishima K; Adachi J; Kurisu K; Yamasaki F; Tominaga T; Kumabe T; Ueki K; Higuchi F; Yamamoto T; Ishikawa E; Takeshima H; Yamashita S; Arita K; Hirano H; Yamada S; Matsutani M;
    Neurol Med Chir (Tokyo); 2014; 54(4):290-301. PubMed ID: 24739422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carmustine wafer implantation when surgical cavity is communicating with cerebral ventricles: technical considerations on a clinical series.
    Della Puppa A; Rossetto M; Ciccarino P; Denaro L; Rotilio A; d'Avella D; Scienza R
    World Neurosurg; 2011; 76(1-2):156-9; discussion 67-8. PubMed ID: 21839967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incorporating BCNU wafers into malignant glioma treatment: European case studies.
    Balossier A; Dörner L; Emery E; Heese O; Mehdorn HM; Menei P; Singh J
    Clin Drug Investig; 2010; 30(3):195-204. PubMed ID: 20155992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk management in the treatment of malignant gliomas with BCNU wafer implants.
    Giese A; Bock HC; Kantelhardt SR; Rohde V
    Cent Eur Neurosurg; 2010 Nov; 71(4):199-206. PubMed ID: 20063259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Risk Factors for Adverse Events after Implantation of BCNU Wafers in High-grade Gliomas].
    Yoshida M; Yamaguchi S; Ishi Y; Endo S; Motegi H; Kobayashi H; Asaoka K; Kamoshima Y; Terasaka S; Houkin K
    No Shinkei Geka; 2015 Jul; 43(7):603-10. PubMed ID: 26136324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early Postoperative Expansion of Parenchymal High-intensity Areas on T2-weighted Imaging Predicts Delayed Cerebral Edema Caused by Carmustine Wafer Implantation in Patients with High-grade Glioma.
    Masuda Y; Ishikawa E; Yamamoto T; Matsuda M; Akutsu H; Kohzuki H; Nakai K; Okamoto E; Takano S; Masumoto T; Matsumura A
    Magn Reson Med Sci; 2016 Jul; 15(3):299-307. PubMed ID: 26726015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraoperative Ventricular Opening has No Effect on Complication Development Following BCNU Wafer Implantation for Malignant Glioma.
    Matsuda R; Maeoka R; Tokuda N; Nakazawa T; Morimoto T; Kotsugi M; Takeshima Y; Tamura K; Yamada S; Nishimura F; Nakagawa I; Park YS; Nakase H
    World Neurosurg; 2023 Mar; 171():e707-e713. PubMed ID: 36574919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose escalation of carmustine in surgically implanted polymers in patients with recurrent malignant glioma: a New Approaches to Brain Tumor Therapy CNS Consortium trial.
    Olivi A; Grossman SA; Tatter S; Barker F; Judy K; Olsen J; Bruce J; Hilt D; Fisher J; Piantadosi S;
    J Clin Oncol; 2003 May; 21(9):1845-9. PubMed ID: 12721262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intraoperative BCNU Wafer Implantation for High-Grade Glioma--A Questionnaire Targeting Japanese Neurosurgeons].
    Ishikawa E; Yamamoto T
    Gan To Kagaku Ryoho; 2016 May; 43(5):603-7. PubMed ID: 27210091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of carmustine wafer implantation on tumor bed cysts and peritumoral brain edema.
    Hasegawa Y; Iuchi T; Sakaida T; Yokoi S; Kawasaki K
    J Clin Neurosci; 2016 Sep; 31():67-71. PubMed ID: 27430412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of tumor bed cysts after chemotherapeutic wafer implantation. Report of four cases.
    McGirt MJ; Villavicencio AT; Bulsara KR; Friedman HS; Friedman AH
    J Neurosurg; 2002 May; 96(5):941-5. PubMed ID: 12005403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The first 3 months after BCNU wafers implantation in high-grade glioma patients: clinical and radiological considerations on a clinical series.
    Della Puppa A; Rossetto M; Ciccarino P; Del Moro G; Rotilio A; Manara R; Paola Gardiman M; Denaro L; d'Avella D; Scienza R
    Acta Neurochir (Wien); 2010 Nov; 152(11):1923-31. PubMed ID: 20703889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma.
    Westphal M; Hilt DC; Bortey E; Delavault P; Olivares R; Warnke PC; Whittle IR; Jääskeläinen J; Ram Z
    Neuro Oncol; 2003 Apr; 5(2):79-88. PubMed ID: 12672279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of interstitial BCNU chemotherapy in the treatment of malignant glioma.
    Engelhard HH
    Surg Neurol; 2000 May; 53(5):458-64. PubMed ID: 10874145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of Recurrence After Resection of Malignant Gliomas With BCNU Wafer Implants: Retrospective Review in a Single Institution.
    Shimato S; Nishizawa T; Ohshima T; Imai T; Goto S; Yamamoto T; Kato K
    World Neurosurg; 2016 Jun; 90():340-347. PubMed ID: 26960286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.